RESEARCH-USE BIOSIMILAR ANTIBODY

Bersanlimab

Monoclonal antibody · IgG1

ICAM1IgG1RUO

Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects.

TARGETICAM1
YMonoclonal antibody
CATALOGSC-BS-724
CATALOG NUMBERSC-BS-724
MOLECULAR WEIGHTApprox. 144.22 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Bersanlimab (BI-505) is a fully human monoclonal antibody that targets intercellular adhesion molecule-1 (ICAM-1 or CD54). Bersanlimab has anticancer effects.

Bersanlimab is a recombinant research-use antibody directed against ICAM1.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Bersanlimab | StellaCyte